Literature DB >> 32548046

Level and Factors Associated with Participation in Population-Based Cancer Screening in Safranbolu District of Karabuk, Turkey.

Raziye Özdemir1, Fatma TÜrkmen Çevik2, Duygu Kes3, Merve Karacali4, Simge ÖzgÜner5.   

Abstract

BACKGROUND: Cervix, breast and colorectal cancers are included in the national population-based screening (PBS) program in Turkey. This study aimed to assess participation in PBSs for these cancers and to identify factors associated with participation in screenings in Safranbolu district of Karabuk, Turkey in 2016-2017.
METHODS: In this cross-sectional study, separate studying groups for cervix, breast and colorectal cancers were identified, taking into account the target age range specified in the national screening standards. The sample size was determined to be 374 for cervical cancer, 371 for breast cancer and 373 for colorectal cancer in the Epi-Info StatCalc program with a prevalence of 50%, a 95% Confidence Interval (CI) and a 5% error margin. The results of the data collected through face-to-face interview using questionnaires were evaluated with Chi-square tests (P<0.05) and included in the binary logistic regression model.
RESULTS: Participation in PBS at least once between 2011 and 2016 years was 26.2% for cervical cancer, 27.6% for breast cancer and 31.6% for colorectal cancer, whereas the level of PBS or opportunistic screening at least once was 51.1%, 42.7% and 32.2%, respectively. A 2.9-fold increase in participation for the cervical cancer screening was associated with informing women about cervical cancer by the family physicians. Being married and living in the district center showed associations with a higher rate of participation for colorectal cancer screening.
CONCLUSION: Participation in PBS was low for the 5.5-year period. More effort is needed to increase the effectiveness of the program.
Copyright © Iranian Public Health Association & Tehran University of Medical Sciences.

Entities:  

Keywords:  Breast; Cervix; Colorectal; Population-based cancer screening; Turkey

Year:  2020        PMID: 32548046      PMCID: PMC7283187     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


Introduction

Increased numbers of cancers due to changes in the demographic structure of communities and the spread of cancer risk factors have created a significant burden of disease in developing countries as well as in developed countries (1). In Turkey, cancer is the second-leading cause-of-death, following cardiovascular diseases (2), and about 148000 new cancer cases occurred in 2012 (3). The most common types of cancer are lung, prostate, bladder and colorectal for men and breast, thyroid, colorectal and stomach cancers for women (3). WHO recommends that countries should implement cancer control programs, including surveillance, prevention, early detection, diagnosis/treatment and palliative care services to reduce the growing burden of cancer diseases. In Turkey, the first national cancer control program was designed in 2008 and updated in 2013 (4). The program focuses on two essential activities in the early detection of cancer. The first is to increase the level of individuals’ awareness of cancer symptoms and signs to detect them and to ensure that persons apply to the health facility. The second is the detection of cancer in the asymptomatic period by population-based screening (PBS) programs for breast, cervix and colorectal cancers (4). The PBSs presented their national screening standards in Table 1 are available free of charge in the cancer early detection and screening centers. The provision of program integration of primary care workers is critical for the success of PBSs targeted to reach 70% of the eligible population for screening. In the program, family physicians (FPs) are given responsibility for inviting individuals to PBS, reporting screening results and directing persons who have a suspicious test result to the hospital for further examination and follow-up (4).
Table 1:

Target population, screening tests and screening intervals for cancers with national screening standards

Cancer typeTarget populationScreening testScreening interval
CervixWomen 30–65 yr of agePap-smear testOnce every five years
HPV test*Once every five years
BreastWomen 40–69 yr of ageMammographyOnce every two years
ColorectalWomen and men 50–70 yr of ageFaecal occult blood testOnce every two years
ColonoscopyOnce every 10 years

It was started on Aug 1, 2014.

Target population, screening tests and screening intervals for cancers with national screening standards It was started on Aug 1, 2014. PBS programs can reduce the burden of disease and mortality due to breast, cervical and colorectal cancers (1, 5–8). However, because of the lack of organized screening programs in developing countries, cancer is often diagnosed at a late stage leading to a decrease in the survival rate and an increase in disease burden and treatment costs (9, 10). It is important to know the level of functioning and performance of the current program which may help decision-makers for future planning and improvement of the services. The aim of this study was to assess participation in PBSs for cervical, breast and colorectal cancers and to identify factors associated with participation in screenings between Jan 2011 and Jun 2016 in Safranbolu district of Karabuk.

Methods

This cross-sectional study carried out in 2016–2017 years in Safranbolu district of Karabuk Province, northwest Turkey. Separate studying groups for cervix, breast and colorectal cancers were identified, taking into account the target age range specified in the national screening standards. The target population sizes determined by using data from the Turkish Statistical Institute (TURKSTAT) were 13836 for cervical cancer, 10530 for breast cancer and 13230 for colorectal cancer. The sample size was calculated to be 374 for cervical cancer, 371 for breast cancer and 373 for colorectal cancer, with a prevalence of 50% (unknown prevalence), 95% confidence intervals (CI) and a 5% error margin in the Epi-Info-7 StatCalc. In this manner, total study sample included 1118 individuals. The study groups were distributed in proportion to the population living in the district center and the villages. The number of people over 18 yr of age residing in Safranbolu which has 20 neigh-bourhoods was obtained from TURKSTAT, and then seven clusters were formed based on population density. Sixty villages of Safranbolu were divided into another seven groups according to the responsibility areas of FPs. Seven neighbour-hoods and 20 villages were randomly selected from the groups formed. While collecting data from all neighbourhoods, however, not all villages could be visited for each cancer type due to logistical problems. Data were collected from 10 villages for cervical cancer, four villages for breast cancer and 18 villages for colorectal cancer. The interviews were conducted starting from a different street in the neighbourhoods and villages for each type of cancer, and one questionnaire for only one cancer type was filled out with an individual. Total 29 people refused to participate in the study. Finally, the questionnaires were completed with 1131 people. The dependent variable was the level of participation in PBS for cervical, breast and colorectal cancers between Jan 2011 and Jun 2016. The level of PBS included invited and uninvited screenings. Invited screening indicated the proportion of individuals invited to PBS by the primary care workers to the total number of people in the study group, whereas uninvited screening expressed the proportion of individuals who had PBS by their own decision without invitation to the total number of people in the study group. Invitation coverage was calculated as the proportion of individuals in the eligible target age range receiving a screening invitation over the total number of the participants (11). The level of opportunistic screening was determined because it would also affect participation in PBS. The independent variables were age, gender, place of residence, marital status, education level, employment status, husband’s education level, husband’s employment status, number of child, household income level, cancer patient in family, awareness of the PBS program and obtaining information about relevant cancer from FPs. The data were collected through face-to-face interviews. Questionnaires, prepared by the researchers, included 47 items for cervix cancer, 50 items for breast cancer and 52 items for colorectal cancer. A pilot survey was conducted in a neighbourhood of Karabuk, where was outside of the study area, with 17 people. The data were summarized as proportions and analyzed by the chi-square test and binary logistic regression. Variables with a statistically significant association on univariate analysis (P<0.05) were included in the logistic regression model. The ethical approval and permission to conduct the study were obtained from Karabuk University Non-Interventional Clinical Research Ethics Board (No: 2015/10) and Karabuk Public Health Directorate respectively. In addition, verbal consent was obtained from all individuals for voluntary participation.

Results

Overall, 1131 individuals, including 374 women for cervical cancer, 384 women for breast cancer and 373 women and men for colorectal cancer, were reached. For cervix cancer, the overall invitation coverage for PBS was 39.0%. The levels of invited and un-invited screenings were 16.6% and 11.8%, respectively. In this group, more than one-third of the women had undergone opportunistic screening; 26.2% of women had at least one PBS, and 51.0% of those had at least one screening (population-based or opportunistic) (Fig. 1). Two women’s test results were found suspicious after the PBSs. One of them applied to the hospital and was diagnosed with cervical intraepithelial neoplasia following further examination.
Fig. 1:

Screening activities for cervix, breast and colorectal cancers in Safranbolu, January 2011–June 2016 *Population-based screening at least once with or without invitation **Population-based or opportunistic screening at least once

Screening activities for cervix, breast and colorectal cancers in Safranbolu, January 2011–June 2016 *Population-based screening at least once with or without invitation **Population-based or opportunistic screening at least once In the screening activity for breast cancer, opportunistic screening of 24.7% was followed by invited screening of 16.9% and uninvited screening of 13.0%. The proportion of women who had PBS at least once was 27.6% (Fig. 1). There were no women with a suspicious test result in this group. Invitation coverage of PBS for colorectal cancer was 41.3%. The proportion of invited individuals to screening for colorectal cancer was higher than the others; however, the proportion of uninvited participants was as low as 1.6%. About one-third of the individuals had a screening at least once (Fig. 1). Ten individuals had a suspicious test result, however, only five of them applied to the hospital for further examination, and one person was diagnosed with in-situ cancer. The levels of never-screened individuals were 78.6% for cervical cancer, 88.8% for breast cancer and 90.1% for colorectal cancer before 2011. These levels were 49.2% for cervical cancer, 57.3% for breast cancer and 67.0% for colorectal cancer between 2011 and 2016 (Fig. 2).
Fig. 2:

Distribution of screenings (population-based or opportunistic) for cervix, breast and colorectal cancers by screening time in Safranbolu

Distribution of screenings (population-based or opportunistic) for cervix, breast and colorectal cancers by screening time in Safranbolu In Univariate analysis, participation in PBS for cervical cancer was higher in women who were aware of the screening program and informed about cervical cancer by FP (P<0.001). In logistic regression analysis, unawareness of cervical cancer screening program was decreased participation in screening by 2.8 times (P= 0.005). Participation in screening in the women not informed about cervical cancer by FP was low by 2.9 times (P<0.001). Other variables did not affect the participation rate (P>0.05) (Table 2).
Table 2:

The association between participation in population-based cervical cancer screening and independent variables (screened= 0, non-screened= 1)

VariableScreenedNot screenedUnivariate analysisLogistic regression analysis
n (%*)n (%*)Chi-squarePOR95% CIP
Age group
  30–4744 (25.3)130 (74.7)0.1410.707-
  48–6554 (27.0)146 (73.0)
Place of residence
  District centre83 (27.4)220 (72.6)1.1680.280
  Village15 (21.1)56 (78.9)
Marital status
  Married87 (27.0)235 (73.0)0.7960.372
  Unmarried**11 (21.2)41 (78.8)
The number of child
  None15 (23.1)50 (76.9)1.6070.448
  1–344 (29.7)104 (70.3)
  ≥439 (24.2)122 (75.8)
Education level
  Primary school and below75 (26.6)207 (73.4)0.0910.762
  Secondary school or above23 (25.0)69 (75.0)
Employment status
  Employed12 (24.5)37 (75.5)0.0860.770
  Unemployed86 (26.5)239 (73.5)
Husband’s education level
  Primary school and below39 (23.8)125 (76.2)1.4250.261
  Secondary school or above48 (29.6)114 (70.4)
Husband’s employment status
  Employed53 (27.3)141 (72.7)
  Unemployed2 (16.7)10 (83.3)0.6560.720
  Retired32 (26.9)87 (73.1)
Monthly household income
  ≤1500 liras (450 EUR)52 (28.0)134 (72.0)
  >1500 liras (450 EUR)46 (24.5)142 (75.5)0.5890.443
Cancer patient in the family
  Yes32 (24.6)98 (75.5)
  No66 (27.0)178 (73.0)0.260.610
Awareness of cervical cancer screening program
  Yes (ref)86 (34.1)166 (65.9)1.0
  No12 (9.8)110 (90.2)25.0830.0002.8[1.4–5.7]0.005
Informed about cervical cancer by the family physician
  Yes (ref)76 (38.2)123 (61.8)1.0
  No22 (12.6)153 (87.4)31.6060.0002.9[1.6–5.2]0.000
  Total98 (26.2)276 (73.8)

ref: Reference variable

Row percentage

Single, widowed, divorced and separated

The association between participation in population-based cervical cancer screening and independent variables (screened= 0, non-screened= 1) ref: Reference variable Row percentage Single, widowed, divorced and separated The awareness of the screening program was the main factor affecting participation in breast cancer screening (OR= 2.8, P= 0.010). Also, the rate of participation was decreased by 4.1 times in women who had not undergone clinical examination by the FP (95%CI 1.0–17.3, P= 0.051) (Table 3).
Table 3:

The association between participation in population-based breast cancer screening and independent variables (screened= 0, non-screened= 1)

VariableScreenedNot screenedUnivariate analysisLogistic regression analysis
n% *n% *Chi-squarePOR95% CIP
Age group
  40–4950 (27.9)129 (72.1)0.1120.945
  50–5937 (28.8)95 (72.0)
  60–6919 (26.0)54 (74.0)
Place of residence
  District centre82 (27.9)212 (72.1)0.0520.820
  Village24 (26.7)66 (73.3)
Marital Status
  Married86 (26.5)239 (73.5)1.3820.268
  Unmarried **20 (33.9)39 (66.1)
The number of child
  None5 (41.7)7 (58.3)3.4310.18
  1–380 (25.6)232 (74.4)
  ≥421 (35.0)39 (65.0)
Education level
  Primary school and below73 (25.0)219 (75.0)4.1360.0421.6[0.9–2.6]0.099
  Secondary school or above (ref)33 (35.9)59 (64.1)1.0
Employment status
  Employed16 (31.4)35 (68.6)0.4180.518
  Unemployed90 (27.0)243 (73.0)
Husband’s education level
  Primary school and below38 (22.2)133 (77.8)3.5090.061
  Secondary school or above51 (31.3)112 (68.7)
Husband’s employment status
  Employed54 (28.0)139 (72.0)1.9110.385
  Unemployed1 (9.1)10 (90.9)
  Retired34 (26.4)95 (73.6)
Monthly household income
  ≤1500 liras (450 EUR)57 (30.5)130 (69.5)1.510.219
  >1500 liras (450 EUR)49 (24.9)148 (75.1)
Cancer patient in the family
  Yes39 (27.9)101 (72.1)0.0070.933
  No67 (27.5)177 (72.5)
Awareness of breast cancer screening program
  Yes (ref)80 (32.9)163 (67.1)9.3640.0021.0
  No26 (18.4)115 (81.6)2.0[1.2–3.3]0.010
Informed about breast cancer by the family physician
  Yes (ref)62 (33.0)126 (67.0)5.3240.0211.0
  No44 (22.4)152 (77.6)1.6[1.0–2.5]0.058
Doing breast self-exam
  Once a month50 (30.1)116 (69.9)1.0050.605
  Once every 3 months and longer32 (26.4)89 (73.6)
  Non-practicing24 (24.7)73 (75.3)
Clinical examination by family physician
  Yes (ref)6 (66.7)3 (33.3)7.0370.0081.0
  No100 (26.7)275 (73.3)4.1[1.0–17.3]0.051
Total106 (27.6)278 (72.4)

ref: Reference variable

Row percentage

Single, widowed, divorced and separated

The association between participation in population-based breast cancer screening and independent variables (screened= 0, non-screened= 1) ref: Reference variable Row percentage Single, widowed, divorced and separated Being unmarried (OR= 4.1) and living in the village (OR= 2.4) showed independent associations with a lower participation rate for colorectal cancer screening Awareness of colorectal cancer screening program increased participation in screening (P<0.001). There was no participant in the screening among the individuals not given health education about colorectal cancer by the FP (Table 4).
Table 4:

The association between participation in population-based colorectal cancer screening and independent variables (screened= 0, non-screened= 1)

ScreenedNot screenedUnivariate analysisLogistic regression analysis
Variablen%*n%*Chi-squarePOR95% CIP
Age group(yr)
  50–5960 (33.9)117 (66.1)0.7980.372
  60–7058 (29.6)138 (70.4)
Gender
  Female65 (34.6)123 (65.4)1.5140.219
  Male53 (28.6)132 (71.4)
Place of residence
  District centre (ref)99 (36.0)176 (64.0)9.2190.0021.0
  Village19 (19.4)79 (80.6)2.4[1.3–4.2]0.003
Marital Status
  Married (ref)113 (34.5)215 (65.5)9.9670.0011.0
  Unmarried **5 (11.1)40 (88.9)4.1[1.5–10.8]0.005
The number of child
  None6 (42.9)8 (57.1)5.4970.064
  1–393 (34.2)179 (65.8)
  4+19 (21.8)68 (78.2)
Education level
  Primary school and below88 (30.1)204 (69.9)1.3960.237
  Secondary school or above30 (37.0)51 (63.0)
Employment status
  Employed6 (19.4925 (80.6)3.2090.201
  Unemployed54 (30.5)123 (69.5)
  Retired58 (35.2)107 (64.8)
Monthly household income
  ≤1500 liras (450 EUR)55 (26.7)151 (73.3)5.1840.0231.4[0.9–2.1]0.200
  >1500 liras (450 EUR) (ref)63 (37.7)104 (62.3)1.0
Cancer patient in the family
  Yes41 (32.3)86 (67.7)0.0370.847
  No77 (31.3)169 (68.7)
Awareness of colorectal cancer screening program
  Yes116 (59.2)80 (40.8)144.9360.000a
  No2 (1.1)175 (98.9)
Informed about colorectal cancer by the family physician **
  Yes118 (69.0)53 (31.0)--b
  No0 (−)202 (100.0)
  Total118 (31.6)255 (68.4)

ref: Reference variable

Row percentage

Single, widowed, divorced and separated

The analysis was not conducted, because only two individuals were screened among the people unaware of the screening program.

The analysis was not conducted, because no one was screened among the uninformed people.

The association between participation in population-based colorectal cancer screening and independent variables (screened= 0, non-screened= 1) ref: Reference variable Row percentage Single, widowed, divorced and separated The analysis was not conducted, because only two individuals were screened among the people unaware of the screening program. The analysis was not conducted, because no one was screened among the uninformed people.

Discussion

This study presents the level and factors associated with participation in PBSs for cervical, breast and colorectal cancers and provides important information on the performance of early-detection services. The study showed that the proportion of individuals screened by PBSs during the 5.5-year study period was very low in Safranbolu. Especially most of cervical and breast cancer screenings were opportunistic. The awareness of the screening program and screening recommendations made by the FPs were the strong determinants of participation in the screenings. Key indicators reflecting the effectiveness of PBS programs and their acceptability by the community are invitation coverage and participation in screening after invitation (11). This study indicated that these levels were too low. Participation in PBSs is high in developed countries with strong primary care organizations and organized programs (12–14). Organised programs for breast, cervical and colorectal cancers are being conducted successfully in the majority of member states of the European Union. In the member states of the European Union, invitation coverage and participation rates were determined to be 79% and 60% for breast cancer, 59% and 51% for cervical cancer and 33% and 14% for colorectal cancer screening, respectively (11). This study showed that a large part of breast and cervical cancer screenings were performed through opportunistic screenings. Compared to PBS, opportunistic screening has significant limitations. First, opportunistic screenings are available to a limited number of people, and socioeconomically disadvantaged individuals generally cannot access screening services. Women with higher education, of higher social class, living in urban areas and regularly visiting a gynaecologist were more likely to participate in cervical cancer screening than those with no habit of visiting a gynaecologist, of low social class, less educated, disabled, unemployed and with high cervical cancer risk (14). Another limitation of opportunistic screening is that it can cost more than PBS and lead to overuse of screening services (14–16). In Hong Kong, opportunistic screening for cervical cytology had a 40% reduction in a lifetime cervical cancer risk compared to no screening, whereas PBS with conventional or liquid-based cytology once every three, four and five years reduced it by 83%–93% (17). The World Cancer Declaration Progress Report stated that the rate of cervical and breast cancer screening in Turkey had reached 80% and 30%, respectively (18). In this study, the screening level at least once through PBS or opportunistic screening was 51.1% for cervical cancer, 42.7% for breast cancer and 32.2% for colorectal cancer for the 5.5-year period. Considering that the screening for breast and colorectal cancers is done every two years, the screening levels drop to 10.6% for breast and 2.4% for colorectal. The level of screening in Safranbolu is below the national level and show an inability to maintain the continuity of the screenings. This study showed that awareness of the Ministry of Health’s free screening program and to be informed by FPs had a significant impact on individuals’ screening behaviour. The reason for the more successful PBS programs in Europe is that primary care physicians play a supporting, informative and facilitating role for people to participate in these programs (19, 20). However, in this study, low invitation coverage and low health education levels point out the integration problems of FPs into the screening program. Effective health education ensures continuity of screening by increasing awareness and knowledge by individuals. Considering that even in well-organized PBS programs, participation rate in screening has not exceeded 80% (14), the importance of health education for newly launched screening programs can be better understood. In China, the physician’s suggestion of testing was the most effective way to increase the level of colorectal cancer screening, which was low due to the lack of information and socioeconomic and individual obstacles (21). The success of PBS programs is not only due to the high screening coverage but also to conduct further examinations of suspicious test results and by providing treatment and monitoring of lesion-detected cases (22). In this study, half of the persons with suspicious outcomes after screening for cervical and colorectal cancer screenings did not undergo further examination to confirm their test results. The benefits of screenings will be limited unless the follow-up of individuals after screening is performed. This study showed that individuals living in villages and unmarried had fewer FOBTs than individuals living in district center and married. A study in the Basque Country in Spain indicated that gender and socioeconomic differences affected the rate of participation in colorectal cancer screening and the frequency of lesions found in participants (23). In Japan, screening rates for colon, stomach and lung cancers had been reported to increase with marriage, living in a non-metropolitan area, having a high income and employment in a large-scale workplace (24). Although this study has some limitations such as being generalized to a region and having a limited number of independent variables, it highlighted important issues related to the performance of PBSs and the factors affecting participation in PBS. The number of individuals participating in PBS in Safranbolu was far from the target of screening 70% of the eligible population. A large part of breast and cervical cancer screenings constituted opportunistic screenings. The study also highlighted the crucial role of FPs in the provision of preventive services and screenings for the cancers covered by PBS program.

Conclusion

The rate of PBS application between 2011 and 2016 years was very low. There is a need for effective health education activities involving primary care and other levels of healthcare organizations to improve the screening program. Increasing public knowledge related to PBSs’ preventive role may be an effective way to enhance participation in the program. Comprehensive studies are also needed to identify the service providers and healthcare system-related barriers to participation in the screening program.

Ethical considerations

Ethical issues (Including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.
  17 in total

1.  Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.

Authors:  Jane J Kim; Gabriel M Leung; Pauline P S Woo; Sue J Goldie
Journal:  J Public Health (Oxf)       Date:  2004-06       Impact factor: 2.341

Review 2.  Participation in colorectal cancer screening trials after first-time invitation: a systematic review.

Authors:  C Khalid-de Bakker; D Jonkers; K Smits; I Mesters; A Masclee; R Stockbrügger
Journal:  Endoscopy       Date:  2011-12-01       Impact factor: 10.093

3.  Participation rates for organized colorectal cancer screening programmes: an international comparison.

Authors:  Carrie Klabunde; Johannes Blom; Jean-Luc Bulliard; Montse Garcia; Lea Hagoel; Verna Mai; Julietta Patnick; Heather Rozjabek; Carlo Senore; Sven Törnberg
Journal:  J Med Screen       Date:  2015-05-12       Impact factor: 2.136

4.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

5.  A community-based breast cancer screening program for medically underserved women: its effect on disease stage at diagnosis and on hazard of death.

Authors:  Clyde B McCoy; Margaret Pereyra; Lisa R Metsch; Fernando Collado-Mesa; Sarah E Messiah; Sandy Sears
Journal:  Rev Panam Salud Publica       Date:  2004-03

6.  Effectiveness and efficiency of opportunistic cervical cancer screening: comparison with organized screening.

Authors:  Peymané Adab; Sarah M McGhee; Jana Yanova; Chit Ming Wong; Anthony J Hedley
Journal:  Med Care       Date:  2004-06       Impact factor: 2.983

7.  Social inequalities in a population based colorectal cancer screening programme in the Basque Country.

Authors:  Jose Luis Hurtado; Amaia Bacigalupe; Montse Calvo; Santi Esnaola; Nere Mendizabal; Isabel Portillo; Isabel Idigoras; Eduardo Millán; Eunate Arana-Arri
Journal:  BMC Public Health       Date:  2015-10-05       Impact factor: 3.295

8.  Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities.

Authors:  Emmanuela Gakidou; Stella Nordhagen; Ziad Obermeyer
Journal:  PLoS Med       Date:  2008-06-17       Impact factor: 11.069

9.  Global Inequalities in Cervical Cancer Incidence and Mortality are Linked to Deprivation, Low Socioeconomic Status, and Human Development.

Authors:  Gopal K Singh; Romuladus E Azuine; Mohammad Siahpush
Journal:  Int J MCH AIDS       Date:  2012

Review 10.  Screening for colorectal cancer: the role of the primary care physician.

Authors:  John K Triantafillidis; Constantine Vagianos; Aristofanis Gikas; Maria Korontzi; Apostolos Papalois
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-01       Impact factor: 2.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.